Beauty Health Total Liabilities 2020-2024 | SKIN
Beauty Health total liabilities from 2020 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Beauty Health Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $634 |
| 2023 | $870 |
| 2022 | $836 |
| 2021 | $917 |
| 2020 | $253 |
| 2019 | $0 |
| Beauty Health Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $634 |
| 2024-09-30 | $640 |
| 2024-06-30 | $643 |
| 2024-03-31 | $781 |
| 2023-12-31 | $870 |
| 2023-09-30 | $883 |
| 2023-06-30 | $846 |
| 2023-03-31 | $847 |
| 2022-12-31 | $836 |
| 2022-09-30 | $847 |
| 2022-06-30 | $863 |
| 2022-03-31 | $857 |
| 2021-12-31 | $917 |
| 2021-09-30 | $1,140 |
| 2021-06-30 | $326 |
| 2021-03-31 | $528 |
| 2020-12-31 | |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2019-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.217B | $0.334B |
| The Beauty Health Company is a beauty health company. Its flagship brand HydraFacial is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. The Beauty Health Company, formerly known as Vesper Healthcare Acquisition Corp., is based in CHICAGO, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.657B | 25.63 |
| Elevance Health (ELV) | United States | $88.114B | 11.37 |
| CVS Health (CVS) | United States | $76.496B | 9.51 |
| Cencora (COR) | United States | $55.428B | 19.28 |
| DiDi Global (DIDIY) | China | $22.215B | 33.71 |
| Natera (NTRA) | United States | $20.400B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.620B | 13.36 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.158B | 0.00 |
| CochLear (CHEOY) | Australia | $11.298B | 0.00 |
| Doximity (DOCS) | United States | $10.912B | 50.83 |
| Revvity (RVTY) | United States | $10.655B | 18.34 |
| ICON (ICLR) | Ireland | $10.552B | 9.81 |
| Viatris (VTRS) | United States | $10.317B | 3.54 |
| Avantor (AVTR) | United States | $8.750B | 12.71 |
| Medpace Holdings (MEDP) | United States | $8.519B | 22.63 |
| HealthEquity (HQY) | United States | $8.446B | 41.55 |
| Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.822B | 13.37 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.185B | 38.74 |
| Bausch + Lomb (BLCO) | Canada | $4.171B | 24.58 |
| Sotera Health (SHC) | United States | $3.616B | 20.55 |
| Surgery Partners (SGRY) | United States | $3.029B | 39.39 |
| Alignment Healthcare (ALHC) | United States | $2.948B | 0.00 |
| Concentras Parent (CON) | United States | $2.925B | 16.90 |
| Organon (OGN) | United States | $2.280B | 2.42 |
| Ardent Health Partners (ARDT) | United States | $2.179B | 9.29 |
| Progyny (PGNY) | United States | $1.882B | 41.42 |
| Premier (PINC) | United States | $1.877B | 14.24 |
| GeneDx Holdings (WGS) | United States | $1.815B | 69.90 |
| PACS (PACS) | United States | $1.625B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.432B | 28.64 |
| Pediatrix Medical (MD) | United States | $1.278B | 9.73 |
| Teladoc Health (TDOC) | United States | $1.272B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.059B | 0.00 | |
| Agilon Health (AGL) | United States | $1.056B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| Nutex Health (NUTX) | United States | $0.967B | 14.61 |
| CareDx (CDNA) | United States | $0.896B | 14.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.857B | 8.02 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.681B | 4.59 |
| InnovAge Holding (INNV) | United States | $0.570B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 44.83 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.493B | 0.00 |
| LifeMD (LFMD) | United States | $0.439B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.367B | 0.00 |
| SBC Medicals (SBC) | United States | $0.361B | 0.00 |
| Oncology Institute (TOI) | United States | $0.230B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.204B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| KindlyMD (KDLY) | United States | $0.083B | 0.00 |
| So-Young (SY) | China | $0.083B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.049B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Biodesix (BDSX) | United States | $0.032B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |